A US startup called BioBots has taken advantage of advances in 3D printing to add a new and interesting ingredient: the possibilities of this technology for all kinds of medical applications use now joins him in biomaterials and living cells to create tissue live 3D and human bodies in miniature.
The biomanufacturing is not a completely new scientific field, of course, but these engineers have created a bioimpresora 3D that becomes a very economical alternative to machines which tend to be much more complex and expensive – above 100,000 dollars. 3D printers can go to more, and this is a palpable demonstration.
“Biotintas” as a printing material
The BioBot bioimpresora creates a special ink that combined with such biomaterials and living cells could be achieved to create those bodies which could end up being used for transplants. At the moment the idea is the use in the field of the clinical research and testing medications and treatments, and according to its creators is an excellent choice for pharmaceutical.
“We see this as a way to develop personalized therapeutic routines. You can do that patients arrive at the clinic, take some tissue samples, produce 3D thumbnail “for those patients and test different treatments”, explained Danny Cabrera, one of the founders of the project.
The company was born as a project in the room in which lived the two founders, PhD students in computer science and biology at the University of Pennsylvania, and has evolved after achieving small investments and support from various medical institutions. The machine currently costs about $5,000 for developers and medical researchers who want to work with her, and the business model is curious: the of sell different “die” as a basis to create different biomaterials. Ink cartilage kit – no kidding – that launched on the occasion of the event TechCrunch Disrupt will cost $700, for example.